Generic Name and Formulations:
Ramelteon 8mg; tabs.
Takeda Pharmaceutical Company
Indications for ROZEREM:
Take 8mg within 30min of bedtime. Do not take with high-fat/heavy meals (delays effect).
Severe hepatic impairment. Concomitant fluvoxamine.
Severe COPD, severe obstructive sleep apnea: not recommended. Moderate hepatic impairment. Depression. Behavioral changes. Monitor prolactin and testosterone levels if unexplained amenorrhea, galactorrhea, decreased libido, or fertility problems occur. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Hypnotic (melatonin agonist).
See Contraindications. Avoid alcohol. Potentiated by potent inhibitors of CYP1A2, CYP3A4 (eg, ketoconazole), CYP2C9 (eg, fluconazole). Antagonized by potent CYP450 inducers (eg, rifampin).
Somnolence, complex sleep-related behaviors (eg, sleep-driving), dizziness, fatigue; reduced testosterone or cortisol levels, increased prolactin levels (monitor if occurs); anaphylaxis, angioedema, others (see literature).
Tabs—30, 100, 500
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children